Toyooka S - Search Results

1

PIK3CA mutations and copy number gains in human lung cancers.

Yamamoto H, Shigematsu H, Nomura M, Lockwood WW, Sato M, Okumura N, Soh J, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Date H, Lam WL, Minna JD, Gazdar AF. Yamamoto H, et al. Among authors: toyooka s. Cancer Res. 2008 Sep 1;68(17):6913-21. doi: 10.1158/0008-5472.CAN-07-5084. Cancer Res. 2008. PMID: 18757405 Free PMC article.

2

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD. Burbee DG, et al. Among authors: toyooka s. J Natl Cancer Inst. 2001 May 2;93(9):691-9. doi: 10.1093/jnci/93.9.691. J Natl Cancer Inst. 2001. PMID: 11333291 Free PMC article.

3

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Toyooka KO, et al. Among authors: toyooka s. Cancer Res. 2001 Jun 1;61(11):4556-60. Cancer Res. 2001. PMID: 11389090

4

Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Cancer Res. 2001 Aug 1;61(15):5727-30. Cancer Res. 2001. PMID: 11479207

5

Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF. Maruyama R, et al. Among authors: toyooka s, toyooka ko. Cancer Res. 2001 Dec 15;61(24):8659-63. Cancer Res. 2001. PMID: 11751381

6

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF. Maruyama R, et al. Among authors: toyooka s, toyooka ko. Clin Cancer Res. 2002 Feb;8(2):514-9. Clin Cancer Res. 2002. PMID: 11839671

7

Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.

Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Cancer Res. 2002 Jun 15;62(12):3382-6. Cancer Res. 2002. PMID: 12067979

8

Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells.

Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Oncogene. 2002 Jun 20;21(27):4340-4. doi: 10.1038/sj.onc.1205381. Oncogene. 2002. PMID: 12082623

9

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.

Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF. Harada K, et al. Among authors: toyooka s, toyooka ko. Oncogene. 2002 Jun 20;21(27):4345-9. doi: 10.1038/sj.onc.1205446. Oncogene. 2002. PMID: 12082624

10

Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.

Toyooka S, Fukuyama Y, Wistuba II, Tockman MS, Minna JD, Gazdar AF. Toyooka S, et al. Clin Cancer Res. 2002 Jul;8(7):2292-7. Clin Cancer Res. 2002. PMID: 12114433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters